Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06935227

Steri-Strip Tape Use in Unilateral Ectropion Surgery

Postoperative Outcomes of Steri-Strip Surgical Tape Use in Unilateral Ectropion Surgery: A Parallel-Controlled Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
74 (estimated)
Sponsor
Claudia Aristizábal · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Currently, the incidence of involutional and chronic eyelid disorders, such as ectropion, has been increasing, as human life expectancy has risen worldwide (more than 600 million people are aged ≥ 60 years). Ectropion is a common eyelid malposition that causes visual morbidity. It is characterized by eversion of the eyelid margin and has multiple etiologies. Steri-Strip tapes have been used in some ophthalmologic procedures, such as blepharoplasties, where they help prevent infections by acting as a barrier method, are resistant enough to reduce the risk of wound dehiscence, simplify postoperative care, and allow for proper eyelid fissure closure. Their use has been recommended in patients with facial paralysis to prevent keratitis or exposure ulcers. However, current evidence is limited, as their use has only been documented in case series and letters to the editor. Therefore, a randomized controlled clinical trial is proposed to evaluate the postoperative outcomes of Steri-Strip tape use in unilateral ectropion surgery compared to standard postoperative management.

Detailed description

This study will compare the use of Steri-Strip tape in unilateral ectropion surgery with standard postoperative care to assess cosmetic and functional outcomes in the adult population. Participants will be followed up at 8 and 30 days after surgery.

Conditions

Interventions

TypeNameDescription
OTHERUse Steri-Strip in post-surgery + standard careSteri-strip will be maintained for 8 days postoperatively.
OTHERStandard carePostoperative care recommendations.

Timeline

Start date
2025-05-01
Primary completion
2026-02-01
Completion
2026-02-01
First posted
2025-04-20
Last updated
2025-06-11

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT06935227. Inclusion in this directory is not an endorsement.